单片低剂量三重组合疗法与标准剂量单疗法在患有轻度至中度高血压的患者中
Ki-Chul Sung1, Kyungil Park2, Dae-Hee Kim3
1Division of Cardiology, Kangbuk Samsung Hospital, Seoul, Republic of Korea.
Journal of the American College of Cardiology
|February 11, 2026
概括
这项研究表明,单片低剂量组合 (LDC) 氨基二平,洛沙坦和甲基 (LDC-ALC) 有效降低血压. 在轻度至中度高血压患者中,LDC-ALC的疗效与阿姆洛迪平相似,效果优于洛萨坦.
科学领域:
- 心血管医学 心血管医学
- 临床药理学 临床药理学
- 高血压研究 高血压研究
背景情况:
- 单片低剂量组合疗法 (LDC) 是一种改善血压控制的新兴策略.
- 第三阶段试验对于验证新的抗高血压药物治疗至关重要.
研究的目的:
- 为了比较单片超低剂量三重组合 (LDC-ALC) 与高血压标准剂量单疗法.
- 为了评估LDC-ALC对洛迪平和洛萨坦的疗效和安全性.
主要方法:
- 在韩国进行了两项多中心,随机,双盲,主动控制的III期研究 (HM-APOLLO-301和HM-APOLLO-302).
- 轻度至中度高血压的成年人被随机分配给8周的LDC-ALC,安洛迪平或洛萨坦治疗.
- 主要终点是第8周缩水血压 (SBP) 降低,评估非劣势和优势.
主要成果:
- 在301研究中,LDC-ALC在SBP降低方面表现出非低劣于amlodipine,并且在301研究中表现出类似的疗效.
- 在302研究中,LDC-ALC在SBP降低方面与洛萨坦无差,且优于洛萨坦,并降低了更大的腹压血压 (DBP).
- 各组的不良事件相似,治疗中断率低,没有严重的药物相关事件.
结论:
- 单片药片LDC-ALC实现了与阿姆洛迪平类药物相比的血压降低,并且比洛萨坦单片治疗更大.
- LDC-ALC是一种耐受性良好且有效的替代初始治疗方法,用于轻度至中度高血压.
- 这些发现支持LDC-ALC作为与已建立的单一疗法一起验证的战略.
相关概念视频
Drug Dosing: Geriatric Patients
278
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
278
Drug Dosing: Obese Patients
269
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269
Dose Size and Dosing Frequency: Determination Methods
320
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
320
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
250
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
250
Rational Dosage Regimen: Maintenance Dose and Loading Dose
5.6K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
5.6K
Bioavailability Study Design: Single Versus Multiple Dose Studies
251
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
251


